Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding OptiNose, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of OPTN: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders5055+5
Shares32.7M63.0M+30.4M (+93.0%)
Value$119.5M$116.4M−$3.14M (−2.6%)

New holders (13)

Institutions that held OptiNose, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to OPTN in Q4 2022
InstitutionSharesValue% of portfolio
MVM Partners, LLC14,605,263$26.8M9.13%
Great Point Partners LLC7,894,736$14.6M3.02%
Armistice Capital, LLC1,996,491$3.69M0.10%
Nantahala Capital Management, LLC1,450,000$2.68M0.24%
Cheyne Capital Management (UK) LLP394,737$730.3K1.29%
Prescott Group Capital Management, L.L.C.130,000$240.0K0.05%
683 Capital Management, LLC102,528$189.7K0.02%
Boothbay Fund Management, LLC53,687$99.3K0.00%
Marshall Wace, LLP29,831$55.2K0.00%
Shay Capital LLC22,746$42.1K0.03%
Mirabella Financial Services LLP20,186$37.3K0.00%
Acadian Asset Management LLC14,296$26.0K0.00%
Balyasny Asset Management LLC12,308$22.8K0.00%

Sold out (8)

Institutions that held OptiNose, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of OPTN in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
GMT Capital Corp1,110,702$4.07M
EAM Investors, LLC337,513$1.24M
Opaleye Management Inc.90,970$333.0K
Two Sigma Investments, LP38,300$140.0K
Squarepoint Ops LLC20,356$75.0K
Arete Wealth Advisors, LLC12,000$44.0K
Federated Hermes, Inc.207$1.00K
Oxler Private Wealth LLC100$366